Gonorrhoea is a common sexually transmitted infection (STI) that affects millions of people worldwide. Many people who have ...

The UK has started a 'world-first' gonorrhoea vaccination programme that is designed to prevent thousands of cases and save the NHS millions of pounds in the coming decade. The campaign – first ...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. today appointed two obstetricians-gynecologists to the ...

Debio1453 is a first-in-class antibiotic candidate that targets an enzyme that’s essential for the growth of Neisseria ...

The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency ...

Detailed price information for Orasure Tech Inc (OSUR-Q) from The Globe and Mail including charting and trades.

The Bethlehem-based maker of at-home diagnostic tests said it submitted two separate applications to the FDA at the end of ...

OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.